Skip to content

XBI: SPDR S&P Biotech ETF returns, drawdowns and risk

Funds on a single sector of the US market: financials, energy, health care, industrials and more.

Data updated October 2026

XBI · US exchange · USDCategory: US sector ETFsData from June 2020

From June 2020 to October 2026 XBI returned 6.2% a year on average with dividends reinvested, in US dollars: $10,000 invested at the start grew to $14,645.

Its deepest fall was 63.9%, from February 2021 to May 2022, and it has not yet returned to the previous high. Annual volatility was 32.3%; at the last close it was 11.3% below its high.

Against SPY (SPDR S&P 500 ETF Trust), over the 76 months both have data, the correlation of monthly returns was 0.48: they moved together only in part. Beta was 0.80. In months when SPY rose, XBI moved 69% as much on average; in months when SPY fell, 92% as much.

Key figures

Annual return (CAGR)
+6.2%
1-year return
+39.7%
5 years, a year
+4.6%
10 years, a year
—
Annual volatility
32.3%
Maximum drawdown
−63.9%
Sharpe ratio
0.26
Worst year
2022: −25.9%

Trailing returns

PeriodXBISPY
1 year+39.7%+16.6%
3 years, a year+32.1%+23.1%
5 years, a year+4.6%+12.7%

To the last close of October 2026. Periods longer than a year are annualised.

Growth of $10,000: XBI vs SPY

$10,000$20,000202120222023202420252026
XBI — SPDR S&P Biotech ETFSPY — SPDR S&P 500 ETF Trust

Month-end values from July 2020, the first month both funds have data.

XBI drawdowns

-60%-40%-20%0%202120222023202420252026

Percentage below the previous high, weekly.

Returns by calendar year

YearXBISPY
2026(partial)+25.8%+13.3%
2025+35.9%+17.7%
2024+1.0%+24.9%
2023+7.6%+26.2%
2022−25.9%−18.2%
2021−20.4%+28.7%
2020(partial)+33.7%—

How the figures are calculated

Total return in the fund’s trading currency, from end-of-day prices with dividends reinvested on the ex-date. The fund’s own ongoing charges are already reflected in its price; trading costs, taxes and currency conversion are not included. Past returns do not predict future returns.

Sharpe ratio uses the return of short-term government bills in the same currency as the risk-free rate. The growth chart uses month-end values; drawdowns and volatility use daily closes.

Questions

What is the average annual return of XBI?

From June 2020 to October 2026 XBI returned 6.2% a year on average (CAGR) with dividends reinvested, in USD. Over the last 5 years: +4.6% a year. Over the last 12 months: +39.7%.

What was the worst drawdown of XBI?

63.9%, from February 2021 to May 2022; it has not yet returned to the previous high.

How volatile is XBI?

Annual volatility was 32.3% over the period. Its worst month was −17.9% and 54% of months were positive. Worst calendar year: 2022 (−25.9%).

How closely does XBI follow SPY?

Over 76 months the correlation of monthly returns was 0.48, so they moved together only in part, with a beta of 0.80.

Use XBI in a free tool

Other US sector ETFs

Source: MarketStack end-of-day prices, total return with dividends reinvested. Figures are historical and descriptive; they are not forecasts and not investment advice. MEDGE Capital does not recommend buying or selling any instrument. Risk disclaimer.